Psychological Treatment of Co-occurring Anxiety Disorders in Clinical Practice: A Vignette Study

2016 ◽  
Vol 52 (6) ◽  
pp. 480-490 ◽  
Author(s):  
Gavin I. Clark ◽  
Tanya L. Hanstock ◽  
Laura H. Clark
Keyword(s):  
Clinical Practice ◽  
Anxiety Disorders ◽  
Psychological Treatment ◽  
Vignette Study

Anxiety Disorders in Adults

2009 ◽  
Author(s):  
Vladan Starcevic, MD, PhD
Keyword(s):  
Clinical Practice ◽  
Anxiety Disorders ◽  
Real World ◽  
Psychological Treatment ◽  
Comprehensive Approach ◽  
Treatment Approaches ◽  
The Real ◽  
Clinical Complexity ◽  
Therapeutic Procedures

Using the practical yet comprehensive approach found in the first edition, the author considers each anxiety disorder's clinical complexity while simultaneously using an integrative orientation toward finding clinical solutions. The author considers the presentation of each disorder as it occurs and is treated in the "real world" of clinical practice. Finally, the volume addresses effective therapeutic procedures and recommendations, including pharmacological and psychological treatment approaches. A true "must read" for any psychiatrist interested in anxiety disorders.

scholarly journals Virtual Environments for the Treatment of Claustrophobia

1998 ◽  
Vol 3 (3) ◽  
pp. 7-12 ◽  
Author(s):  
C. Botella ◽  
S. Quero ◽  
C. Perpiñá ◽  
R.M. Baños ◽  
M. Alcañiz ◽  
...  
Keyword(s):  
Virtual Reality ◽  
Anxiety Disorders ◽  
Virtual Environments ◽  
Special Interest ◽  
Psychological Treatment ◽  
New Technology ◽  
Color Images ◽  
Health Science ◽  
Technical Aspects ◽  
Video Clips

Virtual Reality (VR) is a new technology that is having a great impact on various areas of health science. The use of VR is of special interest in the treatment of psychological disorders. Reasonable data exist on the effectiveness of this technology in the treatment of different anxiety disorders. The present paper explains in detail a psychological program for the treatment of claustrophobia using VR, whose effectiveness has already been demonstrated. (Botella et al.,1998). In addition, we describe the technical aspects of the software and point out several limitations VR still presents in the area of psychological treatment. Color images and video clips are included with the CDROM version.

scholarly journals Brief Coping Strategy Enhancement for Distressing Voices: an Evaluation in Routine Clinical Practice

2017 ◽  
Vol 46 (2) ◽  
pp. 226-237 ◽  
Author(s):  
Mark Hayward ◽  
Rebecca Edgecumbe ◽  
Anna-Marie Jones ◽  
Clio Berry ◽  
Clara Strauss
Keyword(s):  
Clinical Practice ◽  
Coping Strategy ◽  
Rating Scale ◽  
Psychological Treatment ◽  
Clinical Importance ◽  
Service Evaluation ◽  
Behavioural Therapy ◽  
Routine Clinical Practice ◽  
Psychotic Symptoms ◽  
Distress Scale

Background: Hearing voices can be a common and distressing experience. Psychological treatment in the form of cognitive behavioural therapy for psychosis (CBTp) is effective, but is rarely available to patients. The barriers to increasing access include a lack of time for clinicians to deliver therapy. Emerging evidence suggests that CBTp delivered in brief forms can be effective and offer one solution to increasing access. Aims: We adapted an existing form of CBTp, coping strategy enhancement (CSE), to focus specifically on distressing voices in a brief format. This intervention was evaluated within an uncontrolled study conducted in routine clinical practice. Method: This was a service evaluation comparing pre–post outcomes in patients who had completed CSE over four sessions within a specialist out-patient service within NHS Mental Health Services. The primary outcome was the distress scale of the Psychotic Symptoms Rating Scale – Auditory Hallucinations (PSYRATS-AH). Results: Data were available from 101 patients who had completed therapy. A reduction approaching clinical importance was found on the PSYRATS distress scale post-therapy when compared with the baseline. Conclusions: The findings from this study suggest that CSE, as a focused and brief form of CBTp, can be effective in the treatment of distressing voices within routine clinical practice. Within the context of the limitations of this study, brief CSE may best be viewed as the beginning of a therapeutic conversation and a low-intensity intervention in a stepped approach to the treatment of distressing voices.

scholarly journals Reply: Clinical Practice Guidelines for Anxiety Disorders

2007 ◽  
Vol 52 (1) ◽  
pp. 74-74
Author(s):  
John Walker ◽  
Martin Antony ◽  
Richard Swinson
Keyword(s):  
Clinical Practice ◽  
Anxiety Disorders ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines

scholarly journals Neurocognitive mechanisms of d-cycloserine augmented single-session exposure therapy for anxiety

2019 ◽  
Author(s):  
Andrea Reinecke ◽  
Alecia Nickless ◽  
Michael Browning ◽  
Catherine J. Harmer
Keyword(s):  
Panic Disorder ◽  
Anxiety Disorders ◽  
Exposure Therapy ◽  
Psychological Treatment ◽  
Self Report ◽  
Clinical Effects ◽  
Single Session ◽  
Threat Bias ◽  
Fearful Faces

AbstractObjectiveDrugs targeting the N-Methyl-D-aspartic acid (NMDA) system and the ability to learn new associations have been proposed as potential adjunct treatments to boost the success of exposure therapy for anxiety disorders. However, the effects of the NMDA partial agonist d-cycloserine on psychological treatment have been mixed. We investigated potential neurocognitive mechanisms underlying the clinical effects of d-cycloserine-augmented exposure, to inform the optimal combination of this and similar agents with psychological treatment.MethodsUnmedicated patients with panic disorder were randomised to single-dose d-cycloserine (250mg; N=17) or matching placebo (N=16) 2hrs before one session of exposure therapy. Neurocognitive markers were assessed one day after treatment, including reaction-time based threat bias for fearful faces and amygdala response to threat. Clinical symptom severity was measured using self-report and clinician-rated scales the day before and after treatment, and at 1- and 6-months follow-up. Analysis was by intention-to-treat.ResultsOne day after treatment, threat bias for fearful faces and amygdala threat response were attenuated in the drug compared to the placebo group. Lower amygdala magnitude predicted greater clinical improvement during follow-up across groups. D-cycloserine led to greater clinical recovery at 1-month follow-up (d-cycloserine 71% versus placebo 25%).DiscussionD-cycloserine-augmented single-session exposure therapy reduces amygdala threat response, and this effect predicts later clinical response. These findings highlight a neurocognitive mechanism by which d-cycloserine may exert its augmentative effects on psychological treatment and bring forward a marker that may help understand and facilitate future development of adjunct treatments with CBT for anxiety disorders. (D-cycloserine Augmented CBT for Panic Disorder; clinicaltrials.gov;NCT01680107)

Sign in / Sign up

Export Citation Format

Share Document